LV10749B - Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof - Google Patents

Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof Download PDF

Info

Publication number
LV10749B
LV10749B LVP-93-1204A LV931204A LV10749B LV 10749 B LV10749 B LV 10749B LV 931204 A LV931204 A LV 931204A LV 10749 B LV10749 B LV 10749B
Authority
LV
Latvia
Prior art keywords
die
therapeutic system
transdermal therapeutic
der
layer
Prior art date
Application number
LVP-93-1204A
Other languages
English (en)
Latvian (lv)
Other versions
LV10749A (lv
Inventor
Lothar Deurer
Thomas Hille
Thomas Profitlich
Fritz Stanislaus
Kersten Walter
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of LV10749A publication Critical patent/LV10749A/xx
Publication of LV10749B publication Critical patent/LV10749B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-93-1204A 1992-11-12 1993-11-05 Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof LV10749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238223A DE4238223C1 (de) 1992-11-12 1992-11-12 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung

Publications (2)

Publication Number Publication Date
LV10749A LV10749A (lv) 1995-08-20
LV10749B true LV10749B (en) 1996-06-20

Family

ID=6472735

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1204A LV10749B (en) 1992-11-12 1993-11-05 Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof

Country Status (32)

Country Link
US (1) US5698216A (ro)
EP (1) EP0667774B1 (ro)
JP (1) JP3407073B2 (ro)
KR (1) KR100254573B1 (ro)
CN (1) CN1088457A (ro)
AT (1) ATE156356T1 (ro)
AU (1) AU684256B2 (ro)
CA (1) CA2147274C (ro)
CZ (1) CZ284008B6 (ro)
DE (2) DE4238223C1 (ro)
DK (1) DK0667774T3 (ro)
EE (1) EE03135B1 (ro)
EG (1) EG20527A (ro)
ES (1) ES2105334T3 (ro)
FI (1) FI952269A (ro)
GR (1) GR3024720T3 (ro)
HR (1) HRP931391B1 (ro)
HU (1) HUT72963A (ro)
IL (1) IL107547A (ro)
LT (1) LT3107B (ro)
LV (1) LV10749B (ro)
MD (1) MD937C2 (ro)
MY (1) MY111373A (ro)
NO (1) NO306760B1 (ro)
NZ (1) NZ257136A (ro)
PL (1) PL172999B1 (ro)
RU (1) RU2108812C1 (ro)
SI (1) SI9300589A (ro)
SK (1) SK280185B6 (ro)
WO (1) WO1994010999A1 (ro)
YU (1) YU71293A (ro)
ZA (1) ZA938413B (ro)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
DE3843238C1 (ro) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (ro) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
JP4355469B2 (ja) * 2002-03-08 2009-11-04 日本碍子株式会社 アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法

Also Published As

Publication number Publication date
LTIP1469A (en) 1994-06-15
KR100254573B1 (ko) 2000-05-01
NO951864L (no) 1995-05-11
MD937B2 (ro) 1998-03-31
EP0667774B1 (de) 1997-08-06
LV10749A (lv) 1995-08-20
CZ124495A3 (en) 1996-01-17
CN1088457A (zh) 1994-06-29
FI952269A0 (fi) 1995-05-10
WO1994010999A1 (de) 1994-05-26
NZ257136A (en) 1996-07-26
NO306760B1 (no) 1999-12-20
MD937C2 (ro) 1999-01-31
IL107547A (en) 1996-12-05
KR950703948A (ko) 1995-11-17
PL308531A1 (en) 1995-08-21
HRP931391A2 (en) 1995-02-28
ZA938413B (en) 1994-06-09
GR3024720T3 (en) 1997-12-31
DK0667774T3 (da) 1998-03-23
AU684256B2 (en) 1997-12-11
MD940311A (ro) 1998-03-31
SI9300589A (en) 1994-06-30
FI952269A (fi) 1995-05-10
US5698216A (en) 1997-12-16
JP3407073B2 (ja) 2003-05-19
IL107547A0 (en) 1994-02-27
CA2147274C (en) 2005-12-13
HU9501390D0 (en) 1995-06-28
DE59307089D1 (de) 1997-09-11
RU2108812C1 (ru) 1998-04-20
SK280185B6 (sk) 1999-09-10
CZ284008B6 (cs) 1998-07-15
ATE156356T1 (de) 1997-08-15
MY111373A (en) 1999-12-31
PL172999B1 (pl) 1998-01-30
HRP931391B1 (en) 1999-12-31
ES2105334T3 (es) 1997-10-16
DE4238223C1 (de) 1994-05-26
YU71293A (sh) 1996-07-24
EG20527A (en) 1999-06-30
JPH08502986A (ja) 1996-04-02
EP0667774A1 (de) 1995-08-23
CA2147274A1 (en) 1994-05-26
NO951864D0 (no) 1995-05-11
AU5338594A (en) 1994-06-08
EE03135B1 (et) 1998-12-15
SK59395A3 (en) 1996-05-08
LT3107B (en) 1994-12-27
HUT72963A (en) 1996-06-28

Similar Documents

Publication Publication Date Title
DE4002281C2 (ro)
EP1077688B1 (de) Transdermales therapeutisches system (tts) pergolid enthaltend
DE19837902B4 (de) Transdermalpflaster
EP0680325B1 (de) Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil
DE60201134T2 (de) Zusammenstetzung zur transdermalen Abgabe von Nikotin zum Einstellen des Rauchens
EP0716599B1 (de) TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR ABGABE VON 17-$g(b)-ESTRADIOL UND VERFAHREN ZU SEINER HERSTELLUNG
DD290582A5 (de) Verfahren zur herstellung eines transdermalen therapeutischen systems zur verabreichung von physostigmin an die haut
DE10012908B4 (de) Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10224612A1 (de) Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
DE10137082A1 (de) Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE2741755C2 (de) Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben
EP1372619B1 (de) Verfahren zur herstellung eines hochflexiblen transdermalen therapeutischen systems mit nikotin als wirkstoff
EP1063983B1 (de) Transdermales therapeutisches system (tts) oxybutynin enthaltend
EP0781134B9 (de) Scopolaminpflaster
EP0584126B1 (de) Lanolinderivate als penetrationsfördernde substanzen
EP1152751B1 (de) Desoxypeganin-tts
LV10749B (en) Transdermal therapeutic system for puting physostygmine on the skin and methode for preparing therof
EP0143857B1 (de) Coronartherapeutikum in Form von Weichgelatine-Kapseln
DE3902013A1 (de) Pflaster zur transdermalen anwendung
DE19738643A1 (de) Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase
EP0456792B1 (de) VERBESSERTES TRANSDERMALES SYSTEM ZUR APPLIKATION VON PHARMAKOLOGISCH AKTIVEN VERBINDUNGEN UNTER pH-KONTROLLIERTEN BEDINGUNGEN
EP0559702B1 (de) Retardzubereitung für urapidil
DE4438989A1 (de) Scopolaminpflaster
DE3642066A1 (de) Therapeutisches system
DE102006056783A1 (de) Zubereitung zur transdermalen Verabreichung von Galanthamin